Pfizer and Yilingyi Unveil Interim Results of Digital Health Innovation Project at CIIE, Focused on Family-Centric Smart Health Services

November 7, 2021 (Shanghai, China)Today, at the 4th China International Import Expo, Pfizer and Yilingyi jointly held“Born Free” Digital Innovation Project: Phase AchievementsThe project aims to further enhance public awareness of disease prevention, expand vaccine accessibility, and promote whole-lifecycle health management for mothers and infants through digital innovation, thereby supporting the development of the healthcare industry and public health systems.

Che Yan, Head of Vaccine Marketing for Pfizer Biopharmaceuticals Group China; Chen Yuanhong, Head of Vaccine Sales for Pfizer Biopharmaceuticals Group China; Wei Xin, China Lead for Business Partnerships at Pfizer’s Digital Team; and Yin Xiaopeng, Founder and CEO of 100Yi, attended the press conference.

“With the expansion of diverse public science popularization initiatives and the deepening application of internet-based healthcare services, public demand for preventive screening, health management, and professional consultation continues to rise, thereby accelerating the comprehensive digital transformation of the healthcare sector. Digital innovation will empower efficient, personalized”Patient Lifecycle Management, becoming a key entry point for transforming the healthcare service delivery model.

Health Management Becomes a ‘New Essential Need’.It is reported that in this collaboration, both parties are focusing on serious public health issues preventable by vaccines, and are committed to education and science popularization regarding pneumococcal diseases.Through the matrix of apps and mini-programs under Yilingyi, including the Bugu Doctor app, the Bugu Mama app, and related mini-programsa full-chain digital innovation model, providing expectant mothers and families with newborns with disease prevention knowledge—including information on the 13-valent pneumococcal conjugate vaccine—as well as vaccination guidance, to jointly build a healthy digital vaccination ecosystem. For mothers from the late third trimester through three months postpartum, we have established"Exclusive Doctor Team" comprising four physicians specializing in obstetrics, pediatrics, preventive healthcare, and nutrition, to provide mothers with more professional, comprehensive, compassionate, and engaging services, whileVaccine Reminder Mini ProgramIt also provides a thoughtful service of infant and toddler vaccination reminders for newborn families, helping infants and toddlers receive vaccine protection in time and stay away from disease attacks.

The pilot project went live in mid-September, leading up to the press conference at the China International Import Expo (CIIE),In just over 40 days, more than 2,000 obstetricians and pediatricians actively participated in this project, benefiting over 40,000 expectant and new mothers.Through popular science reading and vaccine education, expectant and new mothers not only acquired professional vaccine knowledge but also enjoyed premium services provided by dedicated physicians, thereby meeting the public’s demand for high-quality health services.

Che Yan, Head of Vaccine Marketing for Pfizer’s Biopharmaceuticals Group in China, stated: “As a science-based, innovative, patient-centric biopharmaceutical company, Pfizer remains committed to its mission of ‘delivering breakthroughs that change patients’ lives.’ We are actively exploring innovative development models and collaborating with startups across China to develop novel and effective digital solutions, thereby jointly harnessing the power of innovation.”“We are highly anticipating a strategic partnership with Yilingyi, a leading emerging internet healthcare platform in China, to leverage digital innovation and other means to better support health management for individuals at all stages of life, thereby contributing to the realization of ‘Healthy China 2030.’”

Yin Xiaopeng, CEO of 100MD, stated, “Against the backdrop of digital transformation in healthcare, it is the mission and responsibility of all healthcare practitioners to create higher-quality, more accessible, and more convenient medical and health services. As an emerging representative of internet-based healthcare platforms, 100MD is committed to building a trusted doctor-patient ecosystem characterized by high engagement and strong retention, deeply integrating medical service resources, and delivering technology-driven, comprehensive, and exclusive online-to-offline healthcare services throughout the entire care continuum. This aligns with Pfizer’s advocacy of”Full-Cycle Health Services for Women and Childrenaligns with the philosophy. We look forward to collaborating with Pfizer to jointly explore new models of full-cycle health management for women and children, providing warmer professional services to new families, and realizing “Empowering Every Family with Limitless Health Potential” mission, hand in handBuilding a Healthy China Together。”